Evogene Ltd. (TLV:EVGN)
392.20
-28.30 (-6.73%)
Apr 24, 2025, 5:24 PM IDT
Evogene Market Cap
Evogene has a market cap or net worth of 25.34 million as of April 25, 2025. Its market cap has decreased by -82.39% in one year.
Market Cap
25.34M
Enterprise Value
38.02M
Revenue
31.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
392.20
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 25.34M, a decrease of -77.60%. That is a compound annual growth rate of -8.18%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 61.79B |
Danel (Adir Yeoshua) | 2.34B |
Kamada | 1.38B |
Bait Bakfar | 933.61M |
Novolog (Pharm-Up 1966) | 802.02M |
Ilex Medical | 703.35M |
BrainsWay | 623.44M |
SofWave Medical | 554.17M |